Pharmaceutical companies face unique challenges due to their rapid digital transformation, adopting Internet of Things (IoT), Artificial Intelligence (AI), and blockchain technologies. However, these technologies, while being beneficial, introduce significant cybersecurity risks that need to be managed effectively. The rise in cyber threats, including ransomware and phishing, threatens sensitive data related to clinical trials, patents, and patient information, potentially eroding customer trust and brand reputation.
The regulatory landscape in India mandates stringent cybersecurity measures to protect sensitive data. Recent regulations such as the ‘National Cyber Security Policy’ and the ‘Data Protection Bill’ set high standards for cybersecurity practices to prevent breaches and avoid severe penalties.
Please click here to read the full article by Sidharrth Shankar, published in Express Pharma.
Sidharrth (Sid) is a seasoned corporate lawyer and also the co-chair of the corporate practice with a core focus on private equity and mergers & acquisitions. Sid has substantial experience advising global private equity funds, multinational corporations and strategic investors on complex cross-border transactions across a broad spectrum of industries over the last two and a half decades, with over two decades in JSA itself.